Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Incremental Utility of Right Ventricular Dysfunction in Patients With Myeloproliferative Neoplasm-Associated Pulmonary Hypertension.

Kim J, Krichevsky S, Xie L, Palumbo MC, Rodriguez-Diego S, Yum B, Brouwer L, Silver RT, Schafer AI, Ritchie EK, Yabut MM, Sosner C, Horn EM, Devereux RB, Scandura JM, Weinsaft JW.

J Am Soc Echocardiogr. 2019 Dec;32(12):1574-1585. doi: 10.1016/j.echo.2019.07.010. Epub 2019 Oct 3.

PMID:
31587969
2.

Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with Increased blasts (<10%) or with other types of disease progression.

Geyer JT, Margolskee E, Krichevsky SA, Cattaneo D, Boiocchi L, Ronchi P, Lunghi F, Scandura JM, Ponzoni M, Hasserjian RP, Gianelli U, Iurlo A, Orazi A.

Haematologica. 2019 Sep 19. pii: haematol.2019.230193. doi: 10.3324/haematol.2019.230193. [Epub ahead of print]

3.

Somatic mutations and cell identity linked by Genotyping of Transcriptomes.

Nam AS, Kim KT, Chaligne R, Izzo F, Ang C, Taylor J, Myers RM, Abu-Zeinah G, Brand R, Omans ND, Alonso A, Sheridan C, Mariani M, Dai X, Harrington E, Pastore A, Cubillos-Ruiz JR, Tam W, Hoffman R, Rabadan R, Scandura JM, Abdel-Wahab O, Smibert P, Landau DA.

Nature. 2019 Jul;571(7765):355-360. doi: 10.1038/s41586-019-1367-0. Epub 2019 Jul 3.

PMID:
31270458
4.

Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia.

Roboz GJ, Ritchie EK, Dault Y, Lam L, Marshall DC, Cruz NM, Hsu HC, Hassane DC, Christos PJ, Ippoliti C, Scandura JM, Guzman ML.

Haematologica. 2018 Aug;103(8):1308-1316. doi: 10.3324/haematol.2017.183418. Epub 2018 May 3.

5.

Conversion of adult endothelium to immunocompetent haematopoietic stem cells.

Lis R, Karrasch CC, Poulos MG, Kunar B, Redmond D, Duran JGB, Badwe CR, Schachterle W, Ginsberg M, Xiang J, Tabrizi AR, Shido K, Rosenwaks Z, Elemento O, Speck NA, Butler JM, Scandura JM, Rafii S.

Nature. 2017 May 25;545(7655):439-445. doi: 10.1038/nature22326. Epub 2017 May 17.

6.

Sox17 drives functional engraftment of endothelium converted from non-vascular cells.

Schachterle W, Badwe CR, Palikuqi B, Kunar B, Ginsberg M, Lis R, Yokoyama M, Elemento O, Scandura JM, Rafii S.

Nat Commun. 2017 Jan 16;8:13963. doi: 10.1038/ncomms13963.

7.

Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem Cells.

Cao Z, Scandura JM, Inghirami GG, Shido K, Ding BS, Rafii S.

Cancer Cell. 2017 Jan 9;31(1):110-126. doi: 10.1016/j.ccell.2016.11.010. Epub 2016 Dec 15.

8.

Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response.

Schneider BJ, Shah MA, Klute K, Ocean A, Popa E, Altorki N, Lieberman M, Schreiner A, Yantiss R, Christos PJ, Palmer R, You D, Viale A, Kermani P, Scandura JM.

Clin Cancer Res. 2017 Jun 1;23(11):2673-2680. doi: 10.1158/1078-0432.CCR-16-1896. Epub 2016 Nov 10.

9.

KRAS AND THE REALITY OF PERSONALIZED MEDICINE IN NON-SMALL CELL LUNG CANCER.

Kilgoz HO, Bender G, Scandura JM, Viale A, Taneri B.

Mol Med. 2016 Sep;22:380-387. doi: 10.2119/molmed.2016.00151. Epub 2016 Jul 7.

10.

Cutting the brakes on hematopoietic regeneration by blocking TGFβ to limit chemotherapy-induced myelosuppression.

Brenet F, Scandura JM.

Mol Cell Oncol. 2015 Apr 18;2(3):e978703. doi: 10.4161/23723556.2014.978703. eCollection 2015 Jul-Sep. Review.

11.

Activation of the vascular niche supports leukemic progression and resistance to chemotherapy.

Poulos MG, Gars EJ, Gutkin MC, Kloss CC, Ginsberg M, Scandura JM, Rafii S, Butler JM.

Exp Hematol. 2014 Nov;42(11):976-986.e3. doi: 10.1016/j.exphem.2014.08.003. Epub 2014 Aug 29.

12.

Reprogramming human endothelial cells to haematopoietic cells requires vascular induction.

Sandler VM, Lis R, Liu Y, Kedem A, James D, Elemento O, Butler JM, Scandura JM, Rafii S.

Nature. 2014 Jul 17;511(7509):312-8. doi: 10.1038/nature13547. Epub 2014 Jul 2.

13.

Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance.

Cao Z, Ding BS, Guo P, Lee SB, Butler JM, Casey SC, Simons M, Tam W, Felsher DW, Shido K, Rafii A, Scandura JM, Rafii S.

Cancer Cell. 2014 Mar 17;25(3):350-65. doi: 10.1016/j.ccr.2014.02.005.

14.

The Rad50 hook domain regulates DNA damage signaling and tumorigenesis.

Roset R, Inagaki A, Hohl M, Brenet F, Lafrance-Vanasse J, Lange J, Scandura JM, Tainer JA, Keeney S, Petrini JH.

Genes Dev. 2014 Mar 1;28(5):451-62. doi: 10.1101/gad.236745.113. Epub 2014 Feb 14.

15.

[TGFβ contribution to hematopoietic regeneration after myelosuppressive chemotherapy].

Brenet F, Scandura JM.

Med Sci (Paris). 2013 Nov;29(11):940-2. doi: 10.1051/medsci/20132911003. Epub 2013 Nov 20. French. No abstract available.

16.

TGFβ restores hematopoietic homeostasis after myelosuppressive chemotherapy.

Brenet F, Kermani P, Spektor R, Rafii S, Scandura JM.

J Exp Med. 2013 Mar 11;210(3):623-39. doi: 10.1084/jem.20121610. Epub 2013 Feb 25.

17.

Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia.

Ritchie EK, Feldman EJ, Christos PJ, Rohan SD, Lagassa CB, Ippoliti C, Scandura JM, Carlson K, Roboz GJ.

Leuk Lymphoma. 2013 Sep;54(9):2003-7. doi: 10.3109/10428194.2012.762093. Epub 2013 Feb 7.

18.

RARγ is essential for retinoic acid induced chromatin remodeling and transcriptional activation in embryonic stem cells.

Kashyap V, Laursen KB, Brenet F, Viale AJ, Scandura JM, Gudas LJ.

J Cell Sci. 2013 Feb 15;126(Pt 4):999-1008. doi: 10.1242/jcs.119701. Epub 2012 Dec 21.

19.

Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer.

Vanharanta S, Shu W, Brenet F, Hakimi AA, Heguy A, Viale A, Reuter VE, Hsieh JJ, Scandura JM, Massagué J.

Nat Med. 2013 Jan;19(1):50-6. doi: 10.1038/nm.3029. Epub 2012 Dec 9.

20.

Development of a vascular niche platform for expansion of repopulating human cord blood stem and progenitor cells.

Butler JM, Gars EJ, James DJ, Nolan DJ, Scandura JM, Rafii S.

Blood. 2012 Aug 9;120(6):1344-7. doi: 10.1182/blood-2011-12-398115. Epub 2012 Jun 18.

21.

Imatinib resistance and microcytic erythrocytosis in a KitV558Δ;T669I/+ gatekeeper-mutant mouse model of gastrointestinal stromal tumor.

Bosbach B, Deshpande S, Rossi F, Shieh JH, Sommer G, de Stanchina E, Veach DR, Scandura JM, Manova-Todorova K, Moore MA, Antonescu CR, Besmer P.

Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):E2276-83. doi: 10.1073/pnas.1115240109. Epub 2012 May 31.

22.

Frequent alterations and epigenetic silencing of differentiation pathway genes in structurally rearranged liposarcomas.

Taylor BS, DeCarolis PL, Angeles CV, Brenet F, Schultz N, Antonescu CR, Scandura JM, Sander C, Viale AJ, Socci ND, Singer S.

Cancer Discov. 2011 Dec;1(7):587-97. doi: 10.1158/2159-8290.CD-11-0181.

23.

Are low-intensity induction strategies better for older patients with acute myeloid leukemia?

Roboz GJ, Wissa U, Ritchie EK, Gergis U, Mayer S, Scandura JM, Christos PJ, Feldman EJ.

Leuk Res. 2012 Apr;36(4):407-12. doi: 10.1016/j.leukres.2011.12.019. Epub 2012 Feb 8.

24.

Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML.

Scandura JM, Roboz GJ, Moh M, Morawa E, Brenet F, Bose JR, Villegas L, Gergis US, Mayer SA, Ippoliti CM, Curcio TJ, Ritchie EK, Feldman EJ.

Blood. 2011 Aug 11;118(6):1472-80. doi: 10.1182/blood-2010-11-320093. Epub 2011 May 25.

25.

DNA methylation of the first exon is tightly linked to transcriptional silencing.

Brenet F, Moh M, Funk P, Feierstein E, Viale AJ, Socci ND, Scandura JM.

PLoS One. 2011 Jan 18;6(1):e14524. doi: 10.1371/journal.pone.0014524.

26.

Epigenomic reorganization of the clustered Hox genes in embryonic stem cells induced by retinoic acid.

Kashyap V, Gudas LJ, Brenet F, Funk P, Viale A, Scandura JM.

J Biol Chem. 2011 Feb 4;286(5):3250-60. doi: 10.1074/jbc.M110.157545. Epub 2010 Nov 18.

27.

Tumor promoting properties of the ETS protein MEF in ovarian cancer.

Yao JJ, Liu Y, Lacorazza HD, Soslow RA, Scandura JM, Nimer SD, Hedvat CV.

Oncogene. 2007 Jun 7;26(27):4032-7. Epub 2007 Jan 8.

PMID:
17213815
28.

Advances in the molecular genetics of acute leukemia.

Scandura JM.

Curr Oncol Rep. 2005 Sep;7(5):323-32. Review.

PMID:
16091192
29.

Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation.

Scandura JM, Boccuni P, Massagué J, Nimer SD.

Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15231-6. Epub 2004 Oct 11. Erratum in: Proc Natl Acad Sci U S A. 2004 Nov 23;101(47):16707.

30.

Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells.

MacGrogan D, Kalakonda N, Alvarez S, Scandura JM, Boccuni P, Johansson B, Nimer SD.

Genes Chromosomes Cancer. 2004 Nov;41(3):203-13.

PMID:
15334543
31.

The human L(3)MBT polycomb group protein is a transcriptional repressor and interacts physically and functionally with TEL (ETV6).

Boccuni P, MacGrogan D, Scandura JM, Nimer SD.

J Biol Chem. 2003 Apr 25;278(17):15412-20. Epub 2003 Feb 14.

32.

Transcription factor fusions in acute leukemia: variations on a theme.

Scandura JM, Boccuni P, Cammenga J, Nimer SD.

Oncogene. 2002 May 13;21(21):3422-44. Review.

33.

Structural and functional characterization of platelet receptor-mediated factor VIII binding.

Ahmad SS, Scandura JM, Walsh PN.

J Biol Chem. 2000 Apr 28;275(17):13071-81.

34.

The mechanism by which heparin promotes the inhibition of coagulation factor XIa by protease nexin-2.

Zhang Y, Scandura JM, Van Nostrand WE, Walsh PN.

J Biol Chem. 1997 Oct 17;272(42):26139-44.

35.

Progress curve analysis of the kinetics with which blood coagulation factor XIa is inhibited by protease nexin-2.

Scandura JM, Zhang Y, Van Nostrand WE, Walsh PN.

Biochemistry. 1997 Jan 14;36(2):412-20.

PMID:
9003194
36.
37.

A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin.

Scandura JM, Ahmad SS, Walsh PN.

Biochemistry. 1996 Jul 9;35(27):8890-902.

PMID:
8688425
38.

Extra-scope transfer in learning mathematical strategies.

Scandura JM, Durnin JH.

J Educ Psychol. 1968 Oct;59(5):350-4. No abstract available.

PMID:
5722405
39.

"What is learned" in mathematical discovery.

Roughead WG, Scandura JM.

J Educ Psychol. 1968 Aug;59(4):283-9. No abstract available.

PMID:
5672244
40.

Learning verbal and symbolic statements of mathematical rules.

Scandura JM.

J Educ Psychol. 1967 Dec;58(6):356-64. No abstract available.

PMID:
4169505
41.

Learning principles in paired-associate lists.

Scandura JM.

Psychol Rep. 1967 Feb;20(1):329-30. No abstract available.

PMID:
6037820
42.

Familiarization and one-trial learning: a positive interaction.

Scandura JM.

Psychol Rep. 1965 Aug;17(1):27-38. No abstract available.

PMID:
5826490
43.

FAMILIARIZATION AND CUE SELECTION.

SCANDURA JM.

Psychol Rep. 1965 Feb;16:19-22. No abstract available.

PMID:
14283962

Supplemental Content

Loading ...
Support Center